Literature DB >> 12595436

Nitric oxide partially controls Coxiella burnetii phase II infection in mouse primary macrophages.

Dario S Zamboni1, Michel Rabinovitch.   

Abstract

In most primary or continuous cell cultures infected with the Q-fever agent Coxiella burnetii, bacteria are typically sheltered in phagolysosome-like, large replicative vacuoles (LRVs). We recently reported that only a small proportion of mouse peritoneal macrophages (PMPhi) infected with a nonvirulent, phase II strain of C. burnetii developed LRVs and that their relative bacterial load increased only slowly. In the majority of infected PMPhi, the bacteria were confined to the small vesicles. We show here that nitric oxide (NO) induced by the bacteria partially accounts for the restricted development of LRVs in primary macrophages. Thus, (i) PMPhi and bone marrow-derived macrophages (BMMPhi) challenged with phase II C. burnetii produced significant amounts of NO; (ii) the NO synthase inhibitors aminoguanidine and N-methyl-L-arginine reduced the production of NO and increased the frequency of LRVs (although the relative bacterial loads of individual LRVs did not change, the estimated loads per well increased appreciably); (iii) gamma interferon (IFN-gamma) or the NO donor sodium nitroprusside, added to BMMPhi prior to or after infection, reduced the development and the relative bacterial loads of LRVs and lowered the yield of viable bacteria recovered from the cultures; and (iv) these effects of IFN-gamma may not be entirely dependent on the production of NO since IFN-gamma also controlled the infection in macrophages from inducible NO synthase knockout mice. It remains to be determined whether NO reduced the development of LRVs by acting directly on the bacteria; by acting on the traffic, fusion, or fission of cell vesicles; or by a combination of these mechanisms.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12595436      PMCID: PMC148841          DOI: 10.1128/IAI.71.3.1225-1233.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  42 in total

1.  Subversion of monocyte functions by coxiella burnetii: impairment of the cross-talk between alphavbeta3 integrin and CR3.

Authors:  C Capo; F P Lindberg; S Meconi; Y Zaffran; G Tardei; E J Brown; D Raoult; J L Mege
Journal:  J Immunol       Date:  1999-12-01       Impact factor: 5.422

Review 2.  Q fever epidemiology and pathogenesis.

Authors:  L Norlander
Journal:  Microbes Infect       Date:  2000-04       Impact factor: 2.700

Review 3.  Intracellular vs extracellular recognition of pathogens--common concepts in mammals and flies.

Authors:  Stephen E Girardin; Philippe J Sansonetti; Dana J Philpott
Journal:  Trends Microbiol       Date:  2002-04       Impact factor: 17.079

4.  In vitro evaluation of immunity to Coxiella burnetii.

Authors:  D J Hinrichs; T R Jerrells
Journal:  J Immunol       Date:  1976-09       Impact factor: 5.422

5.  Mouse resident peritoneal macrophages partially control in vitro infection with Coxiella burnetii phase II.

Authors:  Dario S Zamboni; Renato A Mortara; Edna Freymuller; Michel Rabinovitch
Journal:  Microbes Infect       Date:  2002-05       Impact factor: 2.700

6.  Induced production of nitric oxide and sensitivity of alveolar macrophages derived from mice with different sensitivity to Coxiella burnetii.

Authors:  K Yoshiie; S Matayoshi; T Fujimura; N Maeno; H Oda
Journal:  Acta Virol       Date:  1999-10       Impact factor: 1.162

7.  Host and bacterial factors involved in the innate ability of mouse macrophages to eliminate internalized unopsonized Escherichia coli.

Authors:  T S Hamrick; E A Havell; J R Horton; P E Orndorff
Journal:  Infect Immun       Date:  2000-01       Impact factor: 3.441

8.  Coxiella burnetii localizes in a Rab7-labeled compartment with autophagic characteristics.

Authors:  Walter Berón; Maximiliano G Gutierrez; Michel Rabinovitch; Maria I Colombo
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

9.  Interaction between Coxiella burnetii and guinea pig peritoneal macrophages.

Authors:  R A Kishimoto; J S Walker
Journal:  Infect Immun       Date:  1976-08       Impact factor: 3.441

10.  Nitric oxide inhibits Coxiella burnetii replication and parasitophorous vacuole maturation.

Authors:  Dale Howe; Lorraine F Barrows; Nicole M Lindstrom; Robert A Heinzen
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

View more
  39 in total

1.  A novel pathway for inducible nitric-oxide synthase activation through inflammasomes.

Authors:  Carina L Buzzo; Julia C Campopiano; Liliana M Massis; Silvia L Lage; Alexandra A Cassado; Rafael Leme-Souza; Larissa D Cunha; Momtchilo Russo; Dario S Zamboni; Gustavo P Amarante-Mendes; Karina R Bortoluci
Journal:  J Biol Chem       Date:  2010-08-11       Impact factor: 5.157

2.  Coxiella burnetii acid phosphatase inhibits the release of reactive oxygen intermediates in polymorphonuclear leukocytes.

Authors:  J Hill; J E Samuel
Journal:  Infect Immun       Date:  2010-11-15       Impact factor: 3.441

3.  Immunological cell type characterization and Th1-Th17 cytokine production in a mouse model of Gaucher disease.

Authors:  Manoj Kumar Pandey; Reena Rani; Wujuan Zhang; Kenneth Setchell; Gregory A Grabowski
Journal:  Mol Genet Metab       Date:  2012-04-30       Impact factor: 4.797

4.  A method for purifying obligate intracellular Coxiella burnetii that employs digitonin lysis of host cells.

Authors:  Diane C Cockrell; Paul A Beare; Elizabeth R Fischer; Dale Howe; Robert A Heinzen
Journal:  J Microbiol Methods       Date:  2008-01-12       Impact factor: 2.363

5.  Inhibition of macrophage migration inhibitory factor reduces diabetic nephropathy in type II diabetes mice.

Authors:  Zhigang Wang; Meng Wei; Meng Wang; Lei Chen; Hua Liu; Yi Ren; Kehui Shi; Hongli Jiang
Journal:  Inflammation       Date:  2014-12       Impact factor: 4.092

6.  Potential for colonization of O111:H25 atypical enteropathogenic E. coli.

Authors:  Marta O Domingos; Keyde C M Melo; Irys Viana Neves; Cristiane M Mota; Rita C Ruiz; Bruna S Melo; Raphael C Lima; Denise S P Q Horton; Monamaris M Borges; Marcia R Franzolin
Journal:  J Microbiol       Date:  2016-10-29       Impact factor: 3.422

7.  Primary Role for Toll-Like Receptor-Driven Tumor Necrosis Factor Rather than Cytosolic Immune Detection in Restricting Coxiella burnetii Phase II Replication within Mouse Macrophages.

Authors:  William P Bradley; Mark A Boyer; Hieu T Nguyen; L Dillon Birdwell; Janet Yu; Juliana M Ribeiro; Susan R Weiss; Dario S Zamboni; Craig R Roy; Sunny Shin
Journal:  Infect Immun       Date:  2016-03-24       Impact factor: 3.441

Review 8.  Molecular pathogenesis of the obligate intracellular bacterium Coxiella burnetii.

Authors:  Erin J van Schaik; Chen Chen; Katja Mertens; Mary M Weber; James E Samuel
Journal:  Nat Rev Microbiol       Date:  2013-06-24       Impact factor: 60.633

9.  Combination therapy with tamoxifen and amphotericin B in experimental cutaneous leishmaniasis.

Authors:  Cristiana T Trinconi; Juliana Q Reimão; Jenicer K U Yokoyama-Yasunaka; Danilo C Miguel; Silvia R B Uliana
Journal:  Antimicrob Agents Chemother       Date:  2014-02-18       Impact factor: 5.191

10.  Attenuated Coxiella burnetii phase II causes a febrile response in gamma interferon knockout and Toll-like receptor 2 knockout mice and protects against reinfection.

Authors:  Javier Ochoa-Repáraz; Jami Sentissi; Theresa Trunkle; Carol Riccardi; David W Pascual
Journal:  Infect Immun       Date:  2007-09-24       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.